$831 Million is the total value of Ikarian Capital, LLC's 140 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 49.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SRPT | Sell | SAREPTA THERAPEUTICS INCput | $44,524,106 | +218.4% | 3,673 | -97.0% | 5.36% | +140.5% |
| IMVT | Sell | IMMUNOVANT INCcall | $27,755,970 | +348.5% | 7,230 | -97.8% | 3.34% | +239.0% |
| SRPT | Sell | SAREPTA THERAPEUTICS INCcall | $25,735,006 | +916.8% | 2,123 | -90.4% | 3.10% | +668.2% |
| IMVT | Sell | IMMUNOVANT INCput | $21,245,026 | +1373.6% | 5,534 | -92.7% | 2.56% | +1010.9% |
| Sell | NUVALENT INCcall | $11,009,815 | +5833.7% | 2,395 | -45.6% | 1.32% | +4313.3% | |
| KRYS | Sell | KRYSTAL BIOTECH INCput | $9,802,000 | +710.6% | 845 | -91.8% | 1.18% | +510.9% |
| REPL | Sell | REPLIMUNE GROUP INCput | $9,304,418 | +15.1% | 5,438 | -98.4% | 1.12% | -13.1% |
| CRSP | Sell | CRISPR THERAPEUTICS AGput | $9,255,021 | -17.6% | 2,039 | -99.0% | 1.11% | -37.8% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INCput | $9,007,264 | +3.9% | 1,018 | -99.0% | 1.08% | -21.5% |
| NVAX | Sell | NOVAVAX INCput | $8,783,568 | +195.5% | 12,132 | -97.0% | 1.06% | +123.5% |
| BBIO | Sell | BRIDGEBIO PHARMA INCcall | $8,053,398 | -61.9% | 3,054 | -99.8% | 0.97% | -71.2% |
| RCUS | Sell | ARCUS BIOSCIENCES INCcall | $7,180,000 | +76.8% | 4,000 | -98.0% | 0.86% | +33.5% |
| Sell | DISC MEDICINE INC | $6,707,146 | -37.1% | 142,766 | -40.5% | 0.81% | -52.4% | |
| IMGN | Sell | IMMUNOGEN INC | $6,191,871 | -26.7% | 390,162 | -12.9% | 0.74% | -44.6% |
| IDYA | Sell | IDEAYA BIOSCIENCES INC | $5,853,284 | -49.3% | 216,949 | -55.8% | 0.70% | -61.7% |
| IMGN | Sell | IMMUNOGEN INCcall | $5,662,416 | -14.3% | 3,568 | -99.0% | 0.68% | -35.3% |
| NVAX | Sell | NOVAVAX INCcall | $5,163,568 | +73.7% | 7,132 | -98.2% | 0.62% | +31.3% |
| RCUS | Sell | ARCUS BIOSCIENCES INC | $4,575,025 | -19.6% | 254,876 | -9.0% | 0.55% | -39.3% |
| Sell | VENTYX BIOSCIENCES INCput | $4,282,209 | -65.1% | 1,233 | -99.7% | 0.52% | -73.6% | |
| ACRS | Sell | ACLARIS THERAPEUTICS INCput | $4,079,175 | -50.6% | 5,955 | -99.3% | 0.49% | -62.7% |
| REPL | Sell | REPLIMUNE GROUP INCcall | $3,978,075 | -25.0% | 2,325 | -99.0% | 0.48% | -43.2% |
| INSM | Sell | INSMED INC | $3,911,226 | -61.8% | 154,900 | -68.1% | 0.47% | -71.2% |
| Sell | ASTRIA THERAPEUTICS INC | $2,796,060 | -42.1% | 374,807 | -35.3% | 0.34% | -56.3% | |
| Sell | BIOHAVEN LTD | $2,760,650 | -73.0% | 106,138 | -75.2% | 0.33% | -79.6% | |
| APLS | Sell | APELLIS PHARMACEUTICALS INCput | $1,567,248 | -87.1% | 412 | -99.7% | 0.19% | -90.2% |
| Sell | ACELYRIN INCcall | $1,392,273 | -33.4% | 1,369 | -98.6% | 0.17% | -49.8% | |
| ABOS | Sell | ACUMEN PHARMACEUTICALS INC | $1,308,350 | -58.5% | 315,265 | -51.9% | 0.16% | -68.7% |
| TERN | Sell | TERNS PHARMACEUTICALS INCcall | $1,006,000 | -42.5% | 2,000 | -99.0% | 0.12% | -56.6% |
| TERN | Sell | TERNS PHARMACEUTICALS INC | $832,365 | -69.8% | 165,480 | -47.5% | 0.10% | -77.3% |
| IMUX | Sell | IMMUNIC INC | $661,501 | -59.5% | 450,000 | -30.8% | 0.08% | -69.2% |
| HOOK | Sell | HOOKIPA PHARMA INC | $326,958 | -38.1% | 530,776 | -11.5% | 0.04% | -53.6% |
| STOK | Sell | STOKE THERAPEUTICS INCcall | $197,000 | -91.4% | 500 | -99.8% | 0.02% | -93.4% |
| MREO | Sell | MEREO BIOPHARMA GROUP PLCspon ads | $191,281 | -36.3% | 591,676 | -33.6% | 0.02% | -52.1% |
| CRSP | Sell | CRISPR THERAPEUTICS AGcall | $177,021 | -98.4% | 39 | -100.0% | 0.02% | -98.8% |
| SCPH | Sell | SCPHARMACEUTICALS INC | $132,767 | -91.3% | 18,647 | -87.6% | 0.02% | -93.4% |
| RLMD | Sell | RELMADA THERAPEUTICS INC | $121,107 | -24.8% | 40,369 | -38.4% | 0.02% | -42.3% |
| OCUL | Sell | OCULAR THERAPEUTIX INC | $67,793 | -86.9% | 21,590 | -78.4% | 0.01% | -90.2% |
| STOK | Sell | STOKE THERAPEUTICS INC | $47,736 | -93.6% | 12,116 | -82.8% | 0.01% | -95.0% |
| Sell | FINCH THERAPEUTICS GROUP INC | $35,149 | -48.0% | 6,892 | -12.9% | 0.00% | -63.6% | |
| Sell | ROIVANT SCIENCES LTD | $21,270 | -99.1% | 1,821 | -99.2% | 0.00% | -99.2% | |
| BCLI | Sell | BRAINSTORM CELL THERAPEUTICS | $18,057 | -95.4% | 90,242 | -52.5% | 0.00% | -96.8% |
| INSM | Sell | INSMED INCcall | $5,050 | -99.9% | 2 | -100.0% | 0.00% | -99.9% |
| Sell | ASLAN PHARMACEUTICALS LTDspon ads new | $6,215 | -79.2% | 35,420 | -78.4% | 0.00% | -80.0% | |
| ERYP | Exit | PHAXIAM THERAPEUTICS S Asponsored adr | $0 | – | -3,019 | -100.0% | 0.00% | – |
| FGEN | Sell | FIBROGEN INC | $2,393 | -99.6% | 2,774 | -98.8% | 0.00% | -100.0% |
| MDGL | Exit | MADRIGAL PHARMACEUTICALS INC | $0 | – | -75 | -100.0% | -0.00% | – |
| SYBX | Exit | SYNLOGIC INC | $0 | – | -306,757 | -100.0% | -0.02% | – |
| KDNY | Exit | CHINOOK THERAPEUTICS INC | $0 | – | -283,464 | -100.0% | -0.02% | – |
| ASND | Exit | ASCENDIS PHARMA A/Ssponsored adr | $0 | – | -2,090 | -100.0% | -0.03% | – |
| CNTB | Exit | CONNECT BIOPHARMA HLDGS LTDads | $0 | – | -219,501 | -100.0% | -0.04% | – |
| PNT | Exit | POINT BIOPHARMA GLOBAL INC | $0 | – | -28,784 | -100.0% | -0.04% | – |
| ELDN | Exit | ELEDON PHARMACEUTICALS INC | $0 | – | -221,830 | -100.0% | -0.05% | – |
| MRSN | Exit | MERSANA THERAPEUTICS INCcall | $0 | – | -110,600 | -100.0% | -0.06% | – |
| RETA | Exit | REATA PHARMACEUTICALS INCcl a | $0 | – | -5,472 | -100.0% | -0.09% | – |
| XFOR | Exit | X4 PHARMACEUTICALS INC | $0 | – | -349,133 | -100.0% | -0.11% | – |
| ARDX | Exit | ARDELYX INC | $0 | – | -278,825 | -100.0% | -0.15% | – |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -35,000 | -100.0% | -0.15% | – |
| FGEN | Exit | FIBROGEN INCput | $0 | – | -379,300 | -100.0% | -0.16% | – |
| RPHM | Exit | RENEO PHARMACEUTICALS INC | $0 | – | -155,819 | -100.0% | -0.16% | – |
| FGEN | Exit | FIBROGEN INCcall | $0 | – | -400,000 | -100.0% | -0.17% | – |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -412,628 | -100.0% | -0.22% | – |
| MRUS | Exit | MERUS N V | $0 | – | -63,125 | -100.0% | -0.26% | – |
| LEGN | Exit | LEGEND BIOTECH CORPsponsored ads | $0 | – | -25,000 | -100.0% | -0.28% | – |
| QURE | Exit | UNIQURE NVcall | $0 | – | -154,400 | -100.0% | -0.28% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS IN | $0 | – | -160,200 | -100.0% | -0.28% | – |
| Exit | DICE THERAPEUTICS INCput | $0 | – | -43,600 | -100.0% | -0.32% | – | |
| ACRS | Exit | ACLARIS THERAPEUTICS INC | $0 | – | -200,163 | -100.0% | -0.33% | – |
| DCPH | Exit | DECIPHERA PHARMACEUTICALS IN | $0 | – | -174,510 | -100.0% | -0.39% | – |
| BBIO | Exit | BRIDGEBIO PHARMA INCput | $0 | – | -150,000 | -100.0% | -0.41% | – |
| ARWR | Exit | ARROWHEAD PHARMACEUTICALS IN | $0 | – | -130,000 | -100.0% | -0.74% | – |
| LEGN | Exit | LEGEND BIOTECH CORPcall | $0 | – | -68,800 | -100.0% | -0.76% | – |
| BCYC | Exit | BICYCLE THERAPEUTICS PLCsponsored ads | $0 | – | -203,037 | -100.0% | -0.82% | – |
| XENE | Exit | XENON PHARMACEUTICALS INC | $0 | – | -135,486 | -100.0% | -0.83% | – |
| Exit | BIOHAVEN LTDcall | $0 | – | -225,000 | -100.0% | -0.86% | – | |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INCcall | $0 | – | -200,000 | -100.0% | -0.88% | – |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INCput | $0 | – | -211,400 | -100.0% | -0.93% | – |
| BMEA | Exit | BIOMEA FUSION INC | $0 | – | -275,875 | -100.0% | -0.96% | – |
| BMEA | Exit | BIOMEA FUSION INCput | $0 | – | -286,700 | -100.0% | -1.00% | – |
| RETA | Exit | REATA PHARMACEUTICALS INCcall | $0 | – | -110,000 | -100.0% | -1.79% | – |
| MRK | Exit | MERCK & CO INC | $0 | – | -100,000 | -100.0% | -1.84% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -133,800 | -100.0% | -1.94% | – |
| ARGX | Exit | ARGENX SEcall | $0 | – | -38,000 | -100.0% | -2.36% | – |
| AZN | Exit | ASTRAZENECA PLCcall | $0 | – | -250,000 | -100.0% | -2.85% | – |
| TGTX | Exit | TG THERAPEUTICS INCput | $0 | – | -826,100 | -100.0% | -3.27% | – |
| TGTX | Exit | TG THERAPEUTICS INCcall | $0 | – | -826,100 | -100.0% | -3.27% | – |
| BMEA | Exit | BIOMEA FUSION INCcall | $0 | – | -936,800 | -100.0% | -3.28% | – |
| ARGX | Exit | ARGENX SEput | $0 | – | -132,100 | -100.0% | -8.20% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| XENON PHARMACEUTICALS INC | 15 | Q2 2023 | 1.5% |
| OCULAR THERAPEUTIX INC | 15 | Q3 2023 | 1.4% |
| SAREPTA THERAPEUTICS INC | 14 | Q3 2023 | 6.4% |
| X4 PHARMACEUTICALS INC - PIPE | 14 | Q2 2023 | 1.4% |
| PROTARA THERAPEUTICS INC | 14 | Q3 2023 | 1.2% |
| SPDR SER TR | 13 | Q3 2023 | 9.0% |
| VAXCYTE INC | 13 | Q3 2023 | 2.9% |
| TRACON PHARMACEUTICALS INC | 13 | Q3 2023 | 1.4% |
| MILESTONE PHARMACEUTICALS IN | 13 | Q3 2023 | 1.7% |
| BELLUS HEALTH INC NEW | 13 | Q1 2023 | 1.8% |
View Ikarian Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. | February 14, 2023 | 460,416 | 1.3% |
| X4 Pharmaceuticals, Inc | February 14, 2023 | 349,133 | 0.3% |
| aTYR PHARMA INC | February 14, 2022 | 35,048 | 0.1% |
| Cyclacel Pharmaceuticals, Inc. | February 14, 2022 | 99,422 | 1.0% |
| KalVista Pharmaceuticals, Inc. | February 14, 2022 | 36,576 | 0.2% |
| Lyra Therapeutics, Inc. | February 14, 2022 | 394,536 | 3.0% |
| Odonate Therapeutics, Inc. | February 14, 2022 | 1,340,631 | 3.5% |
| Protara Therapeutics, Inc. | February 14, 2022 | 279,256 | 2.5% |
| Science 37 Holdings, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| scPharmaceuticals Inc. | February 14, 2022 | 901,362 | 3.3% |
View Ikarian Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-04-05 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
View Ikarian Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.